Arama Sonuçları - Ala Abudayyeh

Sonuçları Daraltın
  1. 1
    Paraprotein–Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy

    Paraprotein–Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy Yazar: Kevin W. Finkel, Eric P. Cohen, Anushree C. Shirali, Ala Abudayyeh

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Nuclear receptor 4A (NR4A) family – orphans no more

    Nuclear receptor 4A (NR4A) family – orphans no more Yazar: Stephen Safe, Un-Ho Jin, Benjamin Morpurgo, Ala Abudayyeh, Mandip Singh, Ronald B. Tjalkens

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer

    Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer Yazar: Vijayalekshmi Nair, Sandeep Sreevalsan, Riyaz Basha, Maen Abdelrahim, Ala Abudayyeh, Aline Rodrigues Hoffmann, Stephen Safe

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab

    Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab Yazar: Jamie S. Lin, Daniel Wang, Omar Mamlouk, William F. Glass, Maen Abdelrahim, Cassian Yee, Ala Abudayyeh

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report

    Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report Yazar: Maen Abdelrahim, Abdullah Esmail, Godsfavour Umoru, Kiersten Westhart, Ala Abudayyeh, Ashish Saharia, Rafik M. Ghobrial

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma

    Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma Yazar: Erik Hedrick, Syng‐Ook Lee, Gyungeun Kim, Maen Abdelrahim, Un-Ho Jin, Stephen Safe, Ala Abudayyeh

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma

    Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma Yazar: Rimda Wanchoo, Ala Abudayyeh, Mona Doshi, Amaka Edeani, Ilya Glezerman, Divya Monga, Mitchell H. Rosner, Kenar D. Jhaveri

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression

    Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression Yazar: Santhi D. Konduri, Jimmie Colón, Cheryl H. Baker, Stephen Safe, James L. Abbruzzese, Ala Abudayyeh, Riyaz Basha, Maen Abdelrahim

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Checkpoint inhibitor-related renal vasculitis and use of rituximab

    Checkpoint inhibitor-related renal vasculitis and use of rituximab Yazar: Omar Mamlouk, Jamie S. Lin, Maen Abdelrahim, Amanda Tchakarov, William F. Glass, Umut Selamet, Maryam Buni, Noha Abdel‐Wahab, Ala Abudayyeh

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met

    Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met Yazar: Sabitha Papineni, Sudhakar Chintharlapalli, Mona Abdel Rahim, Syng‐Ook Lee, Robert C. Burghardt, Ala Abudayyeh, C. Baker, Luis Javier Herrera, Stephen Safe

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation

    Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation Yazar: Abdullah Esmail, Mohamed Badheeb, Batool Wael Alnahar, Bushray Almiqlash, Yara Sakr, Bayan Khasawneh, Ebtesam Al-Najjar, Hadeel Al‐Rawi, Ala Abudayyeh, Yaser Rayyan, Maen Abdelrahim

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments

    Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments Yazar: Doaa Bugazia, Ebtesam Al-Najjar, Abdullah Esmail, Saifudeen Abdelrahim, Karen Abboud, Adham Abdelrahim, Godsfavour Umoru, Hashem A. Rayyan, Ala Abudayyeh, Ala‐Eddin Al Moustafa, Maen Abdelrahim

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Oncogenic microRNA‐27a is a target for anticancer agent methyl 2‐cyano‐3,11‐dioxo‐18β‐olean‐1,12‐dien‐30‐oate in colon cancer cells

    Oncogenic microRNA‐27a is a target for anticancer agent methyl 2‐cyano‐3,11‐dioxo‐18β‐olean‐1,12‐dien‐30‐oate in colon cancer cells Yazar: Sudhakar Chintharlapalli, Sabitha Papineni, Maen Abdelrahim, Ala Abudayyeh, Indira Jutooru, Gayathri Chadalapaka, Fei Wu, Susanne U. Mertens‐Talcott, Kathy Vanderlaag, Sung Dae Cho, Roger Smith, Stephen Safe

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis

    Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis Yazar: Maen Abdelrahim, Omar Mamlouk, Heather Lin, Jamie S. Lin, Valda D. Page, Noha Abdel‐Wahab, Joshua T. Swan, Umut Selamet, Cassian Yee, Adi Diab, Wadi N. Suki, Ala Abudayyeh

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View

    Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View Yazar: Maen Abdelrahim, Abdullah Esmail, Ashish Saharia, Ala Abudayyeh, Noha Abdel‐Wahab, Adi Diab, Naoka Murakami, Ahmed O. Kaseb, Jenny C. Chang, A. Osama Gaber, Rafik M. Ghobrial

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Infliximab for the treatment of patients with checkpoint inhibitor associated acute tubular interstitial nephritis

    Infliximab for the treatment of patients with checkpoint inhibitor associated acute tubular interstitial nephritis Yazar: Jamie S. Lin, Omar Mamlouk, Umut Selamet, Amanda Tchakarov, William F. Glass, Rahul A. Sheth, Rachel M. Layman, Ramona Dadu, Noha Abdel‐Wahab, Maen Abdelrahim, Adi Diab, Cassian Yee, Ala Abudayyeh

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature

    Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature Yazar: Noha Abdel‐Wahab, Houssein Safa, Ala Abudayyeh, Daniel H. Johnson, Van Anh Trinh, Chrystia M. Zobniw, Heather Lin, Michael K. Wong, Maen Abdelrahim, A. Osama Gaber, María E. Suärez-Almazor, Adi Diab

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Transplant Oncology: An Evolving Field in Cancer Care

    Transplant Oncology: An Evolving Field in Cancer Care Yazar: Maen Abdelrahim, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, Ashish Saharia, Robert McMillan, David W. Victor, Sudha Kodali, Akshay Shetty, Joy Nolte Fong, Linda W. Moore, Kirk Heyne, A. Osama Gaber, Rafik M. Ghobrial

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Transplant Oncology: An Emerging Discipline of Cancer Treatment

    Transplant Oncology: An Emerging Discipline of Cancer Treatment Yazar: Maen Abdelrahim, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, David W. Victor, Sudha Kodali, Yee Lee Cheah, Caroline J. Simon, Mazen Noureddin, Ashton A. Connor, Ashish Saharia, Linda W. Moore, Kirk Heyne, Ahmed O. Kaseb, A. Osama Gaber, Rafik M. Ghobrial

    Baskı/Yayın Bilgisi 2023
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

    Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience Yazar: Omar Mamlouk, Umut Selamet, Shana Machado, Maen Abdelrahim, William F. Glass, Amanda Tchakarov, Lillian W. Gaber, Amit Lahoti, Biruh Workeneh, Sheldon Chen, Jamie S. Lin, Noha Abdel‐Wahab, Jean Tayar, Huifang Lu, María E. Suärez-Almazor, Nizar M. Tannir, Cassian Yee, Adi Diab, Ala Abudayyeh

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: